Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-09-012570
Filing Date
2009-03-02
Accepted
2009-03-02 17:38:40
Documents
2
Period of Report
2009-02-27

Document Format Files

Seq Description Document Type Size
1 P. MAHAFFY - FORM 3 2-27-2009 rrd235708.html 3  
1 P. MAHAFFY - FORM 3 2-27-2009 rrd235708.xml 3 2125
2 POWER OF ATTORNEY rrd211379_238873.htm EX-24.1 3273
  Complete submission text file 0001181431-09-012570.txt   7265
Mailing Address C/O PHARMION CORP 2525 28TH ST BOULDER CO 80301
Business Address 7205649101
MAHAFFY PATRICK J (Reporting) CIK: 0001266569 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33415 | Film No.: 09648948

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations